thiazoles has been researched along with Crohn Disease in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (16.67) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Barnich, N; Bonnet, R; Chevarin, C; Dalmasso, G; Delmas, J; Faïs, T; Massier, S; Nguyen, HTT; Vazeille, E | 1 |
| Dimmitt, RA; Maclin, J; Thame, KA; Vadlamudi, N | 1 |
| Bilyy, RO; Bouckaert, J; Brument, S; Chalopin, T; Darfeuille-Michaud, A; Deniaud, D; Dumych, TI; Gouin, SG; Guérardel, Y; Moreau, N; Roos, G; Sivignon, A | 1 |
| Alvarez Dorta, D; Barnich, N; Bilyy, RO; Bouckaert, J; Caudan, M; Chalopin, T; Deniaud, D; Dumych, TI; Gouin, SG; Sivignon, A | 1 |
| Davies, GJ; Goddard-Borger, ED; John, A; Petricevic, M; Roth, C; Williams, SJ | 1 |
| Nathwani, D; Shaw, J; Smith, S | 1 |
| LOJACONO, F; SIGAUDO, F | 1 |
| Gotham, S | 1 |
| Bajwa, PJ; Carson, MJ; Cong, Y; Elson, CO; Jeske, DR; Lee, JW; Lytle, C; Straus, DS | 1 |
| Blumberg, RS; Nakajima, A; Wada, K | 1 |
| Eliakim, R; Karmeli, F; Ligumsky, M; Rachmilewitz, D; Simon, P | 1 |
| Saunders, DR; Saunders, MD; Sillery, JK | 1 |
12 other study(ies) available for thiazoles and Crohn Disease
| Article | Year |
|---|---|
Yersiniabactin Siderophore of Crohn's Disease-Associated Adherent-Invasive
Topics: Animals; Autophagy; Crohn Disease; Escherichia coli; Escherichia coli Infections; Intestinal Mucosa; Male; Mice; Mice, Transgenic; Phenols; Thiazoles | 2021 |
Cryptosporidial infection in children with inflammatory bowel disease.
Topics: Adolescent; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Antiparasitic Agents; Case-Control Studies; Child; Child, Preschool; Colitis, Ulcerative; Crohn Disease; Cryptosporidiosis; Cryptosporidium; Diarrhea; Feces; Female; Humans; Immunosuppressive Agents; Male; Nitro Compounds; Patient Readmission; Recurrence; Retrospective Studies; Severity of Illness Index; Thiazoles | 2013 |
Thiazolylaminomannosides as potent antiadhesives of type 1 piliated Escherichia coli isolated from Crohn's disease patients.
Topics: Adhesins, Escherichia coli; Animals; Antigens, CD; Bacterial Adhesion; Binding Sites; Caco-2 Cells; Cell Adhesion Molecules; Colon; Crohn Disease; Escherichia coli; Fimbriae Proteins; Fimbriae, Bacterial; GPI-Linked Proteins; Host-Pathogen Interactions; Humans; Intestines; Jurkat Cells; Mannosides; Mice; Mice, Transgenic; Models, Chemical; Molecular Structure; Thiazoles | 2013 |
Second generation of thiazolylmannosides, FimH antagonists for E. coli-induced Crohn's disease.
Topics: Adhesins, Escherichia coli; Crohn Disease; Enzyme-Linked Immunosorbent Assay; Escherichia coli; Fimbriae Proteins; Humans; Magnetic Resonance Spectroscopy; Mannosides; Microbial Sensitivity Tests; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Thiazoles | 2016 |
Structural and mechanistic insights into a Bacteroides vulgatus retaining N-acetyl-β-galactosaminidase that uses neighbouring group participation.
Topics: Acetylglucosamine; Bacteroides; beta-N-Acetyl-Galactosaminidase; Binding Sites; Catalytic Domain; Crohn Disease; Humans; Molecular Dynamics Simulation; Stereoisomerism; Substrate Specificity; Thiazoles | 2016 |
Nitazoxanide for cryptosporidial infection in Crohn's disease.
Topics: Adult; Animals; Antiprotozoal Agents; Colitis; Crohn Disease; Cryptosporidiosis; Cryptosporidium parvum; Female; Humans; Intestinal Diseases, Parasitic; Nitro Compounds; Opportunistic Infections; Thiazoles | 2008 |
[CLINICAL INVESTIGATIONS OF A NEW PREPARATION WITH HIGH CHEMOTHERAPEUTIC ACTIVITY].
Topics: Anti-Bacterial Agents; Cellulitis; Cholecystitis; Colitis; Crohn Disease; Drug Resistance; Drug Resistance, Microbial; Enteritis; Epididymitis; Humans; Male; Nitrofurans; Orchitis; Respiratory Tract Infections; Sulfonamides; Thiazoles; Thrombophlebitis; Urinary Tract Infections | 1963 |
Digestive Disease Week 2004. Bowel inflammation.
Topics: Azepines; Cholinergic Agents; Colitis, Ulcerative; Crohn Disease; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Isoquinolines; Pyridazines; Tacrolimus; Thiazoles | 2004 |
Fenofibrate represses interleukin-17 and interferon-gamma expression and improves colitis in interleukin-10-deficient mice.
Topics: Age Factors; Animals; Cell Count; Chemokine CXCL10; Chemokines, CXC; Colitis; Crohn Disease; Disease Models, Animal; Fenofibrate; Gene Expression; HT29 Cells; Humans; Hypolipidemic Agents; Interferon-gamma; Interleukin-10; Interleukin-17; Mice; Mice, Inbred C3H; Mice, Knockout; PPAR alpha; Spleen; Th1 Cells; Thiazoles | 2007 |
PPARgamma and inflammatory bowel disease: a new therapeutic target for ulcerative colitis and Crohn's disease.
Topics: Animals; Anti-Inflammatory Agents; Chromans; Colitis, Ulcerative; Crohn Disease; Disease Models, Animal; Inflammation; Intestines; Ligands; Mice; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone | 2001 |
Cytokines and platelet-activating factor in human inflamed colonic mucosa.
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Anti-Idiotypic; Calcimycin; Colitis, Ulcerative; Colon; Crohn Disease; Humans; Imidazoles; Immunoglobulin E; Interleukin-1; Intestinal Mucosa; Mesalamine; Organ Culture Techniques; Platelet Activating Factor; Prednisolone; Sulfasalazine; Thiazoles | 1992 |
Beneficial effects of glucose polymer and an H2-receptor blocker in a patient with a proximal ileostomy.
Topics: Adult; Carbohydrates; Combined Modality Therapy; Crohn Disease; Famotidine; Fluid Therapy; Histamine H2 Antagonists; Humans; Ileostomy; Malabsorption Syndromes; Male; Polymers; Thiazoles | 1989 |